HMOX1 and cholangiocarcinoma: For example, addition of biologic agents to block various kinase enzymes, or to suppress cytoprotective enzymes; NQO1 and HO-1 in CCA cells could increase the susceptibility of CCA to chemotherapeutic drugs [1,20,23].